S
XBIO icon

Sachetta’s Xenetic Biosciences XBIO Stock Holding History

Sachetta’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,259
Closed -$47.9K – 1113
2025
Q3 		$47.9K Hold
15,259
– – 0.02% 271
2025
Q2 		$59.8K Buy
15,259
+4,593
+43% +$13.3K 0.02% 233
2025
Q1 		$27.8K Buy
10,666
+3,295
+45% +$12.9K 0.01% 312
2024
Q4 		$29.4K Sell
7,371
-10,000
-58% -$40.3K 0.01% 319
2024
Q3 		$75K Buy
+17,371
New +$68.4K 0.03% 231

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIP
Alexis Investment Partners Montgomery, Texas $171M AUM 32.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sachetta's XBIO Position: Q4 2025 in Review

Sachetta sold out of Xenetic Biosciences (XBIO) in Q4 2025, closing a stake of 15,259 shares — an estimated $47.9K sold.

Sachetta first reported a position in XBIO in Q3 2024 and held it in 5 quarters. The position peaked at $75K in Q3 2024. 11 funds tracked by Wall St. Rank hold XBIO as of Q4 2025.

  • Sachetta reported no remaining Xenetic Biosciences position as of Q4 2025 after selling out during the quarter.
  • Sachetta sold 15,259 Xenetic Biosciences shares in Q4 2025, an estimated $47.9K.
  • Sachetta first reported a position in Xenetic Biosciences in Q3 2024 and held it in 5 quarters.
  • Sachetta's Xenetic Biosciences position peaked at $75K in Q3 2024.
  • 11 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q4 2025.

Based on Sachetta's 13F filing for Q4 2025, filed 2 Feb 2026.